KELLEY HULL: Open Payments
NPI 1184408965 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,129 in 75 payments from 16 companies in 2025. Trend: 2023 $73 · 2024 $645 · 2025 $1,129
Food & beverage: $1,129
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $236 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 25 | $173 |
| Janssen Biotech, Inc. | 4 | $113 |
| Ipsen Biopharmaceuticals, Inc | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
| Lilly USA, LLC | 4 | $71 |
| Gilead Sciences, Inc. | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Madrigal Pharmaceuticals | 1 | $34 |
Products named: XIFAXAN, RINVOQ, TREMFYA, IQIRVO, DUPIXENT, ENTYVIO, OMVOH, SKYRIZI.
Industry payments across NY — which companies pay providers there.
